Does Physical Exercise Ameliorate Chronic Kidney Disease-Related Complications? The Case of Anaemia and Chronic Kidney Disease-Mineral Bone Disorder

被引:0
作者
Aucella, Filippo [1 ]
Amicone, Maria [2 ]
Ys, Aurora del Mar Perez [1 ]
Aucella, Francesco [1 ]
Gatta, Giuseppe [1 ]
Prencipe, Michele Antonio [1 ]
Riccio, Eleonora [2 ]
Capuano, Ivana [2 ]
Pisani, Antonio [2 ]
Battaglia, Yuri [3 ]
机构
[1] Res Hosp Casa Sollievo Sofferenza Fdn, Dept Med Sci, Nephrol & Dialysis Unit, San Giovanni Rotondo, Italy
[2] Feder II Univ, Dept Publ Hlth, Naples, Italy
[3] Univ Verona, Pederzoli Hosp, Dept Med, Nephrol & Dialysis Unit, Verona, Italy
关键词
Physical exercise; Chronic kidney disease; Dialysis; Chronic kidney disease-mineral bone disorder; Anaemia; RENAL-DISEASE; HEMODIALYSIS-PATIENTS; LACTATE; MARKERS; IMPROVES;
D O I
10.1159/000540659
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background: Physical exercise (PE) can regulate inflammation, cardiovascular health, sarcopenia, anaemia, and bone health in the chronic kidney disease (CKD) population. Experimental and clinical studies both help us better understand the mechanisms that underlie the beneficial effects of the exercise, especially in renal anaemia and CKD-mineral bone disorders (CKD-MBDs). Here, we summarize this evidence, exploring the biological pathways involved, locally released substances, and crosstalk between tissues, but also the shortcomings of current knowledge. Summary: Anaemia: Both in healthy and CKD subjects, PE may mimic hypoxia, inhibiting PHDs; so hydroxylate HIF-alpha subunits may be translocated into the nucleus, resulting in dimerization of HIF-1 alpha and HIF-1 beta , recruitment of p300 and CBP, and ultimately, binding to HREs at target genes to cause activation. However, in CKD subjects acute PE causes higher levels of lactate, leading to iron restriction by upregulating hepatic hepcidin expression, while chronic PE allows an increased lactate clearance and HIF-alpha and VEGF alpha levels, stimulating both erythropoiesis and angiogenesis. CKD-MBD: PE may improve bone health decreasing bone resorption and increasing bone formation throughout at least three main pathways: (a) increasing osteoprotegerin and decreasing RANKL system; (b) decreasing cytokine levels; and (c) stimulating production of myokines and adipokines. Key Messages: Future research needs to be defined to develop evidence-based exercise guidance to provide optimal benefit for CKD using exercise interventions as adjuvant therapy for CKD-related complications such as anaemia and CKD-MBD. (c) 2024 The Author(s). Published by S. Karger AG, Basel
引用
收藏
页码:812 / 820
页数:9
相关论文
共 50 条
  • [1] The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease
    Graciolli, Fabiana G.
    Neves, Katia R.
    Barreto, Fellype
    Barreto, Daniela V.
    dos Reis, Luciene M.
    Canziani, Maria E.
    Sabbagh, Yves
    Carvalho, Aluizio B.
    Jorgetti, Vanda
    Elias, Rosilene M.
    Schiavi, Susan
    Moyses, Rosa M. A.
    KIDNEY INTERNATIONAL, 2017, 91 (06) : 1436 - 1446
  • [2] Management of Chronic Kidney Disease-Mineral Bone Disorder
    Ruf, Kathryn M.
    Clifford, Timothy
    ORTHOPEDICS, 2010, 33 (02) : 98 - 101
  • [3] Pediatric Patients with Chronic Kidney Disease-Mineral Bone Disorder
    Kumar, Juhi
    Furth, Susan L.
    Warady, Bradley A.
    CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM, 2012, 10 (03): : 219 - 234
  • [4] Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder
    Mark R. Hanudel
    Isidro B. Salusky
    Current Osteoporosis Reports, 2017, 15 : 198 - 206
  • [5] A rat model of chronic kidney disease-mineral bone disorder
    Moe, Sharon M.
    Chen, Neal X.
    Seifert, Mark F.
    Sinders, Rachel M.
    Duan, Dana
    Chen, Xianming
    Liang, Yun
    Radcliff, J. Scott
    White, Kenneth E.
    Gattone, Vincent H., II
    KIDNEY INTERNATIONAL, 2009, 75 (02) : 176 - 184
  • [6] UPDATE ON THE TREATMENT OF CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER
    Bover, Jordi
    Farre, Neus
    Andres, Enric
    Canal, Cristina
    Teresa Olaya, Maria
    Alonso, Maite
    Quilez, Begona
    Ballarin, Jose
    JOURNAL OF RENAL CARE, 2009, 35 : 19 - 27
  • [7] Newly Developed Rat Model of Chronic Kidney Disease-Mineral Bone Disorder
    Watanabe, Kentaro
    Fujii, Hideki
    Goto, Shunsuke
    Nakai, Kentaro
    Kono, Keiji
    Watanabe, Shuhei
    Shinohara, Masami
    Nishi, Shinichi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (02) : 170 - 177
  • [8] Chronic kidney disease-mineral and bone disorder: a complex scenario
    Mejia, N.
    Roman-Garcia, P.
    Miar, A. B.
    Tavira, B.
    Cannata-Andia, J. B.
    NEFROLOGIA, 2011, 31 (05): : 514 - 519
  • [9] Cinacalcet Hydrochloride in Chronic Kidney Disease-Mineral Bone Disorder
    Yokoyama, Keitaro
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (09): : 1405 - 1408
  • [10] Bone health in chronic kidney disease-mineral and bone disorder: a clinical case seminar and update
    Aleksova, Jasna
    Ng, Kong W.
    Jung, Caroline
    Zeimer, Howard
    Dwyer, Karen M.
    Milat, Frances
    MacIsaac, Richard J.
    INTERNAL MEDICINE JOURNAL, 2018, 48 (12) : 1435 - 1446